Alessandro Marco Minisini

Author

Also Known As

A M Minisini, A Minisini, A. M. Minisini, A. Minisini, A.M. Minisini, A.M.M. Minisini, Alessandro Marco Minisini, Alessandro M Minisini, Alessandro M. Minisini, Alessandro Marco Minisini

207

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

University of Udine Ospedale Santa Maria della Misericordia di Udine European Institute of Oncology Istituti di Ricovero e Cura a Carattere Scientifico Centro di Riferimento Oncologico

About

Alessandro Marco Minisini is an author at University of Udine specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	18	994
2	Health Sciences	5	5	276
3	Biostatistics	2	2	31
4	Cell Biology	2	2	124
5	Public Health	1	1	10

Alessandro Marco Minisini

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario Marta Bonotto, Lorenzo Gerratana, Elena Poletto, The Oncologist	2014	283
Pattern of metastasis and outcome in patients with breast cancer Lorenzo Gerratana, V. Fanotto, Marta Bonotto, Clinical & Experimental Metastasis Surgical OncologyBreast OncologyMedicineCancer ManagementPathology	2015	212
Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated <i>BRAF</i>-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial Paolo A. Ascierto, Mario Mandalà, Pier Francesco Ferrucci, Journal of Clinical Oncology	2022	208
Taxane-induced nail changes: incidence, clinical presentationand outcome Alessandro Marco Minisini, Antonellá Tosti, Alberto Sobrero, Annals of Oncology PathologyClinical DermatologyDermatologyTaxane-induced Nail ChangesDermatopathology	2003	169
Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications Fabio Puglisi, Alessandro Follador, Alessandro Marco Minisini, Annals of Oncology Baseline Staging TestsBreast OncologyCancer DetectionCancer ScreeningMedicine	2005	158
Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study Marta Pestrin, Silvia Bessi, Fabio Puglisi, Breast Cancer Research and Treatment Breast OncologySingle-agent LapatinibMedicineProof-of-concept StudyPathology	2012	109
Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial Luca Malorni, Giuseppe Curigliano, Alessandro Marco Minisini, Annals of Oncology	2018	94
Prognostic significance of Ape1/ref-1 subcellular localization in non-small cell lung carcinomas. Fabio Puglisi, G. Aprile, Alessandro Marco Minisini, PubMed	2002	86
Role of Mammography, Ultrasound and Large Core Biopsy in the Diagnostic Evaluation of Papillary Breast Lesions Fabio Puglisi, Chiara Zuiani, Massimo Bazzocchi, Oncology	2003	85
Obstetrical complications and the development of postpartum depressive symptoms: a prospective survey of the MATQUID cohort Hélène Verdoux, A.-L. Sutter, Élisabeth Glatigny-Dallay, Acta Psychiatrica Scandinavica	2002	78

Page 1